EIN 13-6180380

American Society of Clinical Oncology (ASCO)

IRS 501(c) type
501(c)(3)
Num. employees
523
Year formed
1965
Most recent tax filings
2022-12-01
NTEE code, primary
Description
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer.
Total revenues
$146,139,860
2022
Total expenses
$144,269,886
2022
Total assets
$251,452,025
2022
Num. employees
523
2022

Program areas at ASCO

See schedule o:scientific & medical education:in 2022, Asco's annual meeting (the Asco annual meeting is the world's premier scientific and educational Clinical Oncology meeting), through over 200 sessions, reached an audience of 34,250 professionals, including over 14,000 professionals from 136 non-us countries, both in-person and online. Through Asco's additional meetings, the Asco gastrointestinal cancers symposium, the Asco genitourinary cancers symposium, the Asco quality care symposium, and the best of Asco annual meeting, a further 9,250 professionals, over 4,000 of whom were from outside the united states, benefited from the education, science, and networking that Asco provided.
See schedule o:research initiatives - tapur/centra:asco's center for research and analytics (centra) leads Asco's efforts in research and related to Clinical cancer research. Major programs and projects include: (1) the targeted agent and profiling utilization registry (tapur) which is a precision medicine basket trial investigating the efficacy of more than 15 different anti-cancer targeted agents in patients with advanced cancers and has enrolled more than 2600 patients since it opened in 2016. In 2022, the tapur team submitted 7 abstracts and 4 manuscripts; (2) Asco's covid-19 registry which includes a database of over 6000 patients with cancer and covid-19 from 2020 to 2022 and research on the database by centra staff and made available to external researchers with a total of 5 submitted manuscripts and 6 abstracts; (3) Asco's member research survey pool, which facilitates research of cancer care providers by disseminating surveys from meritorious survey research projects to Asco members who have agreed to be a part of the survey pool; (4) the state of cancer care in america program, which has a research agenda to assess and report on the state of and changes in cancer care in the us, and (5) Asco's site self-assessment tool and implicit bias training, both of which were developed in collaboration with the association of community cancer centers with the objective of increasing representative of minority enrollment on cancer Clinical trials. Centra also supports workshops, meetings, and research projects with other stakeholders in cancer research, including the nci, the fda's Oncology center for excellence, and other non-profit groups, such as the friends of cancer research.
See schedule o:quality of care initiatives - cancerlinq, quality measures, guidelines and qopi:cancerlinq is a health technology platform, developed and implemented by Asco, that aggregates electronic health record data to improve the quality of care and health outcomes for all patients with cancer and to advance evidence-based research. In 2022, cancerlinq's practice facing quality management and reporting platform smartlinq served 67 Oncology practices and cancer centers across the us, including 3 that joined the network in 2022. Smartlinq was refreshed in 2022 with a new homepage and features. Inside smartlinq, a suite of dashboards, reports, and quality measure tools enable practice teams to track the quality of cancer care automatically and proactively, and the 11 unique reporting dashboards that are part of the cancerlinq insights tool assist oncologists with Clinical decision-making and practice insights. Additionally, through cancerlinq discovery, 10 tumor site-specific real-world datasets have been made available to the research community, and in 2022 these were utilized by a total of 30 cancer researchers across 10 academic institutions. In 2022, there were a total of 6 manuscripts published in peer-reviewed journals and 18 abstracts accepted to scientific meetings that used data from cancerlinq. "quality Oncology practice initiative (qopi). A quality self assessment and improvement program for outpatient medical Oncology and hematology-oncology practices: qopi provides a web-based data collection tool that allows practices to 1) report on various cancer care quality measures, 2) receive analyzed data on practice performance, and 3) compare performance against their peers for data-driven improvement activities. Practices participate annually and over 300 pratices particapted in 2022.quality training program. Asco's quality training program is designed to educate and train hematolgy-onocology practice teams, the techniques of Clinical care and operational performance quality improvement. Recent particpants have included, by intentional recruitment, practices serving urban and rural underserved populations adressing health disparity. 287 Oncology professionals received training in 2022."
Examples of other programs - publications, public information and policy:scientific publications: Asco produces a number of professional publications and general publications focused on Clinical Oncology. Asco publishes high-quality, peer-reviewed scientific papers in its journals: - journal of Clinical Oncology (jco)- jco Oncology practice (jco op)- jco global Oncology (jco go)- jco Clinical cancer informatics (jco cci)- jco precision Oncology (jco po)- Asco daily newsasco also provides content and distribution lists for trade publications. While not owned or published by Asco, the publications cover news and information of interest to the professional Oncology community.patient & public information:asco provides timely, credible, and comprehensive cancer information free of charge through its award-winning website, cancer.net (www.cancer.net), mobile application, and print materials. Cancer.net, which celebrated its 20th anniversary in 2022, covers 120+ types of cancer and cancer-related syndromes and every aspect of cancer care and survivorship, as well as offering timely and trusted cancer information for people affected by global events such as covid-19 and the conflict in ukraine. Additional initiatives included a social media outreach campaign focused on mental health resources for patients and caregivers that received over 3 million impressions, a series of articles debunking common cancer-related myths that received over 400,000 page views, and a content-sharing collaboration with the American cancer Society that resulted in over 38,000 page views of the shared content across both sites in the first year. Over the course of 2022, more than 57 million pages on cancer.net were viewed by 29 million people worldwide. Content is developed and reviewed by an editorial board composed of 200+ medical, surgical, radiation, and pediatric oncologists; multidisciplinary members of the Oncology team such as nurses, physician assistants, and social workers; as well as patient advocates. Information is available in english and spanish, with select resources available in 9 additional languages.policy:asco works to shape a wide range of policy issues that impact the cancer care delivery system and people with cancer. The Society's goal is to ensure that all patients have access to high-quality, affordable cancer care and Oncology practices have the resources needed to provide that care. Key areas of focus include quality and access to care, medical insurance coverage issues, cost, disparities, prevention, survivorship, reimbursement, and support for Clinical cancer research. In 2022, Asco drew public attention to the harms of prior authorization with a policy statement describing the adverse impact of prior authorization on patients and offering several recommendations for addressing concerns.

Grants made by ASCO

GranteeGrant descriptionAmount
Conquer Cancer and Conquer Cancer FDTNContribution$3,514,500
The University of Chicago (UChicago)Contribution$130,000
Yale UniversityContribution$115,833
...and 8 more grants made

Who funds American Society of Clinical Oncology (ASCO)

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Conquer Cancer and Conquer Cancer FDTNCharitable Assistance$9,233,468
Council of Medical Specialty SocietiesSub-Recipient$126,811
Schwab Charitable FundHealth$10,000

Personnel at ASCO

NameTitleCompensation
Clifford A. HudisChief Executive Officer$930,020
Nancy R. DalyChief Executive Officer , Conquer Cancer , the Asco Foundation and Executive Vice President$477,749
Dina L. MichelsChief Operating Officer , Chief Legal Officer and Executive Vice President$618,646
Linda JensenExecutive Vice President and Chief Financial Officer$431,666
Julie R. GralowChief Medical Officer and Executive Vice President$583,947
...and 33 more key personnel

Financials for ASCO

RevenuesFYE 12/2022
Total grants, contributions, etc.$9,250,760
Program services$123,943,513
Investment income and dividends$4,158,517
Tax-exempt bond proceeds$0
Royalty revenue$9,231,347
Net rental income$1,690,189
Net gain from sale of non-inventory assets$-2,134,466
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$146,139,860

Form 990s for ASCO

Fiscal year endingDate received by IRSFormPDF link
2022-122023-11-10990View PDF
2021-122022-11-10990View PDF
2020-122021-11-14990View PDF
2019-122021-02-24990View PDF
2018-122020-02-04990View PDF
...and 9 more Form 990s
Data update history
October 24, 2024
Updated personnel
Identified 2 new personnel
March 8, 2024
Updated personnel
Identified 1 new personnel
January 23, 2024
Updated personnel
Identified 9 new personnel
January 17, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 3, 2024
Used new vendors
Identified 3 new vendors, including , , and
Nonprofit Types
Grantmaking organizationsProfessional associationsBusiness and community development organizationsDisease-focused nonprofitsHeadquarter / parent organizationsCharities
Issues
HealthDiseases and disordersMedical disciplinesCommunity improvementCancerBusiness and industry
Characteristics
Political advocacyLobbyingOperates internationallyNational levelCommunity engagement / volunteeringTax deductible donationsAccepts online donations
General information
Address
2318 Mill Rd 800
Alexandria, VA 22314
Metro area
Washington-Arlington-Alexandria, DC-VA-MD-WV
County
Alexandria city, VA
Website URL
asco.org/ 
Phone
(571) 483-1300
Facebook page
ASCOCancer 
Twitter profile
@asco 
IRS details
EIN
13-6180380
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1965
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G30: Cancer
NAICS code, primary
813920: Professional Associations
Parent/child status
Central organization
California AB-488 details
AB 488 status
May Not Operate or Solicit for Charitable Purposes
Charity Registration status
Delinquent
FTB status revoked
Not revoked
AG Registration Number
CT0220132
FTB Entity ID
3921550
AB 488 data last updated ("as-of") date
2024-11-06
Free account sign-up

Want updates when ASCO has new information, or want to find more organizations like American Society of Clinical Oncology (ASCO)?

Create free Cause IQ account